Jefferies lowered their price target on Tilray Brands , after updating their outlook, saying excluding all the Canadian headwinds, the overall outlook looks compelling.
Out of the 20 analysts, 2 have strong buy ratings, 2 have buy ratings, 13 analysts have hold ratings and the last 3 have sell ratings.
Though they do see some signs of optimism in these quarterly results, mainly that the market share losses have slowed and that the company is now taking market share in both vape and the pre-roll categories.
Though, Jefferies says that the rest of Tilray’s business is doing well, with their international cannabis segment sales up 15% sequentially while wellness sales were up 6% as well.
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions.